Back
Speaker illustration

Doctor Jonathan Tjerkaski

Karolinska Institute, Stockholm (Sweden)

Member of:

European Society of Cardiology

Presentations Articles

The effect of Glucagon-like peptide-1 receptor agonists on cardiovascular outcomes in type 2 diabetes mellitus patients with coronary artery disease

Event: ESC Congress 2024

Topic: Antidiabetic Pharmacotherapy

Session: Diabetes, obesity, and the heart

Access
Like
Thumbnail

Comparison of sodium-glucose co-transporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in myocardial infarction patients with type 2 diabetes

Event: ESC Congress 2023

Topic: Pharmacotherapy

Session: Treatment of acute coronary syndromes in clinical practice

Access
Like
Thumbnail

Comparison between ticagrelor and clopidogrel in high bleeding risk patients with acute coronary syndrome

Event: ESC Congress 2022

Topic: Pharmacotherapy

Session: The role of bleeding in determining antithrombotic treatment in acute coronary syndromes

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources